Ch. 14.4: References and Image Credits

AlShareef, S., & Marwaha, R. (2019). Anabolic steroid use disorder. StatPearls [Internet], retrieved from https://www.ncbi.nlm.nih.gov/books/NBK538174/

Baydala, L., & Canadian Paediatric Society, First Nations, Inuit and Métis Health Committee. (2010). Inhalant abuse. Paediatrics & Child Health, 15(7), 443-448.

Centers for Disease Control and Prevention (CDC). (2013). Addressing prescription drug abuse in the United States: Current activities and future opportunities. Developed by the Behavioral Health Coordinating Committee, Prescription Drug Abuse Subcommittee, U.S. Department of Health and Human Services. Retrieved from https://www.cdc.gov/drugoverdose/pdf/hhs_prescription_drug_abuse_report_09.2013.pdf

Center for Substance Abuse Treatment (CSAT). (2006). Detoxification and substance abuse treatment. Treatment Improvement Protocol (TIP) Series, No. 45. HHS Publication No. (SMA) 15-4131. Rockville, MD: CSAT. Retrieved from https://store.samhsa.gov/system/files/sma15-4131.pdf

Chan, B.., Kondo, K., Freeman, M., Ayers, C., Montgomery, J., & Kansagara, D. (2019). Pharmacotherapy for cocaine use disorder-A systematic review and meta-analysis. Journal of General Internal Medicine, 34(12), 2858-2873.

Department of Justice (DOJ). (2004). A guide for understanding steroids and related substances. U.S. Department of Justice, Drug Enforcement Administration, Diversion Control Division. Retrieved from https://www.deadiversion.usdoj.gov/pubs/brochures/steroids/professionals/

Dodds, T.J. (2017). Prescribed benzodiazepines and suicide risk: A review of the literature. The Primary Care Companion for CNS Disorders, 19(2), e1-e6. Retrieved from http://www.psychiatrist.com/PCC/article/Pages/2017/v19n02/16r02037.aspx  doi: 10.4088/PCC.16r02037

Humphreys, K., Malenka, R.C., Knutson, B., & MacCoun, R.J. (2017). Policy forum: Neuroscience and addiction—Brains, environments, and policy responses to addiction. Science, 356, 1237-1239.

Lopez, G. (2016). It’s not just painkillers and heroin. Americans have a growing alcohol problem too. Vox (December 9). Retrieved from https://www.vox.com/policy-and-politics/2016/12/9/13898956/alcohol-deaths-2015

Mattick, R.P., Breen, C., Kimber, J., & Davoli, M. (2009). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. The Cochrane database of systematic reviews (3). Retrieved from https://researchonline.lshtm.ac.uk/id/eprint/5044/1/5044.pdf

National Center for Complementary and Integrative Health (NCCIH). (2018). St. John’s Wort and depression: In depth. Retrieved from https://nccih.nih.gov/health/stjohnswort/sjw-and-depression.htm

National Institute on Drug Abuse (NIDA). (2017a). Inhalants. Retrieved from https://www.drugabuse.gov/publications/drugfacts/inhalants

National Institute on Drug Abuse (NIDA). (2017b). Over-the-counter medicines. Retrieved from https://www.drugabuse.gov/publications/drugfacts/over-counter-medicines

National Institute on Drug Abuse (NIDA). (2018a). Anabolic steroids. Retrieved from https://www.drugabuse.gov/publications/drugfacts/anabolic-steroids

National Institute on Drug Abuse (NIDA). (2018b). Misuse of prescription drugs. Retrieved from https://www.drugabuse.gov/publications/misuse-prescription-drugs/overview

National Institute on Drug Abuse (NIDA). (2020). Opioid overdose reversal with naloxone (Narcan, Evzio). Retrieved from https://www.drugabuse.gov/related-topics/opioid-overdose-reversal-naloxone-narcan-evzio

National Institute on Drug Abuse (NIDA). (n.d.). Buprenorphine. Retrieved from https://archives.drugabuse.gov/buprenorphine

Portelli, J., Munjal, V., & Leggio, L. (2020). Current and emerging pharmacotherapies for addiction treatment. In A.L. Begun & M. Murray, (Eds.), Routledge handbook of social work and addictive behaviors, (p. 321-342). NY: Routledge.

Substance Abuse and Mental Health Services Administration (SAMHSA). (2019). Natrexone. Retrieved from https://www.samhsa.gov/medication-assisted-treatment/treatment/naltrexone

Suh, J.J., Pettinati, H.M., Kampman, K.M., & O’Brien, C.P. (2006). The status of disulfiram: A half of a century later., Journal of Clinical Psychopharmacology, 26(3), 290-302.

Witkiewitz, K., Saville, K., & Hamreus, K. (2012). Acamprosate for treatment of alcohol dependence: Mechanisms, efficacy, and clinical utility. Therapeutics and Clinical Risk Management, 8, 45-53.

World Health Organization (WHO). (1993). Drug use and sport: Current issues and implications for public health. Programme on substance abuse. Retrieved from https://apps.who.int/iris/bitstream/handle/10665/60747/WHO_PSA_93.3.pdf?sequence=1&isAllowed=y

Zweben , A., & West, B. (2020). Intervening around addictive behaviors. In A.L. Begun & M. Murray, (Eds.), Routledge handbook of social work and addictive behaviors, (p. 298-320). NY: Routledge.